ICOA
AUPH icon

Investment Centers of America’s Aurinia Pharmaceuticals AUPH Stock Holding History

Investment Centers of America’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60,000
Closed -$376K – 26
2017
Q3 		$376K Buy
60,000
+30,000
+100% +$189K 0.03% 391
2017
Q2 		$184K Buy
+30,000
New +$202K 0.01% 551

Other funds holding AUPH

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Investment Centers of America's AUPH Position: Q4 2017 in Review

Investment Centers of America sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2017, closing a stake of 60,000 shares — an estimated $376K sold.

Investment Centers of America first reported a position in AUPH in Q2 2017 and held it in 2 quarters. The position peaked at $376K in Q3 2017. 68 funds tracked by Wall St. Rank hold AUPH as of Q4 2017.

  • Investment Centers of America reported no remaining Aurinia Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 60,000 Aurinia Pharmaceuticals shares in Q4 2017, an estimated $376K.
  • Investment Centers of America first reported a position in Aurinia Pharmaceuticals in Q2 2017 and held it in 2 quarters.
  • Investment Centers of America's Aurinia Pharmaceuticals position peaked at $376K in Q3 2017.
  • 68 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.